News

Some antibodies neutralize the virus effectively, while others bind only weakly. Pinpointing exactly which parts of a virus ...
The Virus That Could’ve Ended Us is Now Saving Lives, Thanks to AI. Story by Arezki Amiri ... The question now is not whether AI can reshape biotechnology, but how far it can take us.
Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...
Scientists have identified dozens of human proteins that SARS-CoV-2, the virus that causes COVID-19, depends on to replicate ...
As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds—ticks.
A drug that targets two parts of the deadly Nipah virus protects against infection in hamsters. And once an animal is ...
As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds - ticks.
Vir Biotechnology has demonstrated consistent progress in its clinical programs, particularly with the initiation of the ECLIPSE Phase III trials for hepatitis delta virus.
New research has suggested that a virus that has typically been thought of as common and harmless may actually be associnrwd with an in creased risk of Par | Cell And Molecular Biology ...
It’s how one gene drive virus can multiply into many. In the new work, Walter’s team tried the technique in mice, infecting them with two different viruses. One was a herpes virus designed to ...